Private Equity Investments

Two-asset continuation vehicle comprising high-quality platforms with recurring revenues, strong margins, high cash conversion, and leading positions in their respective marketsInvestment Date: 2025Geography: EuropeNorthleaf Angle: Northleaf leveraged its long-standing relationship with the general partner, having invested across six funds through primary and secondary transactions. As an existing investor, Northleaf closely tracked the continuation vehicle assets over time, which supported its underwriting of the investment.

24 fund interests (180 underlying companies)Investment Date: 2025Geography: EuropeNorthleaf Angle: Northleaf had strong information access and coverage across the portfolio and, as an existing secondary buyer with the seller, was well positioned as an efficient counterparty.

Seven fund interests (53 underlying companies)Investment Date: 2025Geography: North AmericaNorthleaf Angle: Northleaf was an existing investor with two of the fund managers and had a prior relationship with all six, providing a differentiated angle and access.

Three fund interests (19 underlying companies)Investment Date: 2025Geography: North AmericaNorthleaf Angle: Northleaf had a strong due diligence angle through a longstanding relationship with the general partner and was an existing investor in all three funds as well as a co-investor in 7 of the 19 underlying companies.

Multi-asset continuation vehicle comprising four companies, each holding a leading or strong position within its respective marketInvestment Date: 2025Geography: EuropeNorthleaf Angle: Northleaf has maintained a core relationship with the general partner since 2010, providing access to a small, exclusive syndication process. Northleaf is already an investor in all four assets.

Nine fund interests (124 underlying companies)Investment Date: 2025Geography: North AmericaNorthleaf Angle: Northleaf had existing exposure to 5 out of 6 fund managers through its primary or secondary investments.

Single LP stake in an existing a multi-asset continuation vehicleInvestment Date: 2025Geography: EuropeNorthleaf Angle: Northleaf was an existing investor in the continuation vehicle and a long-term primary backer of the general partner.

Single-asset continuation vehicle in a continuing medical education services provider for pharmaceutical and biotech companiesInvestment Date: 2024Geography: North AmericaNorthleaf Angle: Northleaf had an existing long-standing primary relationship having committed to the general partner's last four funds.

Seven fund interests (47 underlying companies)Investment Date: 2024Geography: EuropeNorthleaf Angle: Northleaf's existing investments and broader private equity platform provided strong information access to a unique mid-market portfolio. 

Two fund interests and a primary fund commitmentInvestment Date: 2024Geography: EuropeNorthleaf Angle: Northleaf received full access to information given the underlying general partner’s desire to build a broader relationship.